From: Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India
Laboratory parameters | Severe malaria n = 58 (%) | Uncomplicated malaria n = 119 (%) | Total number of patients n = 177 (%) | Chi-square (df) | P |
---|---|---|---|---|---|
Leukopenia (WBC < 4000 cells/µl) | 15 (25.9) | 10 (8.4) | 25 (14.1) | 8.4 (1) | 0.0037* |
Leukocytosis (WBC > 10,000 cells/µl) | 6 (10.3) | 0 (0.0) | 6 (3.4) | 9.8 (1) | 0.0018* |
Severe anaemia | 33 (56.9) | 0 (0.0) | 33 (18.7) | 79.5 (1) |  < 0.0001* |
Moderate anaemia | 15 (25.9) | 9 (7.6) | 24 (13.5) | 9.6 (1) | 0.0019* |
Mild anaemia | 38 (65.5) | 39 (32.8) | 67 (37.9) | 15.7 (1) |  < 0.0001* |
Thrombocytopenia (< 150,000 cells/µl) | 52 (89.7) | 64 (53.8) | 116 (65.5) | 20.7 (1) |  < 0.0001* |
Deranged AST | 24 (41.4) | 13 (10.9) | 37 (20.9) | 20.1 (1) |  < 0.0001* |
Deranged ALT | 26 (44.8) | 17 (14.3) | 43 (24.3) | 18.2 (1) |  < 0.0001* |
Serum bilirubin > 2.5 mg/dL | 15 (28.9) | 2 (1.7) | 17 (9.6) | 23.6 (1) |  < 0.0001* |
Mean Hb ± SD | 11.5 ± 1.7 | 13.4 ± 1.9 | – |  | 0.0024* |
Mean RBC count (cells/µl) | 2.51 × 106 | 3.41 × 106 | – |  | 0.0478* |